
9.43 Delayed Data As of 12:00am ET | ![]() Today’s Change | 7.13 Today|||52-Week Range 31.50 | -45.62% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $661.1M |
Anavex Life Sciences Corp. 630 5th Avenue New York New York 10111 |
Christopher U. Missling | Chairman, President, CEO & Secretary |
Stephan Toutain | Chief Operating Officer |
Sandra Boenisch | Chief Financial Officer & Treasurer |
Walter E. Kaufmann | Chief Scientific Officer |
Edward R. Hammond | Chief Medical Officer |